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The Value of Ultrasound-Guided
Tattooing Localization of Nonpalpable
Breast Lesions
Objective: To investigate the value of ultrasound-guided tattooing localization
(US-tattoo) using a charcoal suspension for breast lesions.
Materials and Methods: One hundred sixty-four nonpalpable breast lesions in
134 patients (mean age 47 years; range 30 74 years) were marked with a char-
coal suspension under US guidance. The medical records associated with the
US-tattoo, the pathology results and the follow-up US results were reviewed. 
Results: The average size of the localized lesions was 1.0 cm. The procedure
time was < 5 minutes (range, 2 10 minutes) per lesion. The US-tattoo was well
tolerated in all cases. The only technical difficulty encountered was a needle tip
blockage caused by a large charcoal particle (4.9%). The surgeon easily identi-
fied the tattoo with the exception one case. In addition, surgery could be safely
delayed from one to 57 days after the making US-tattoo. The pathology result
was benign in 108 cases, borderline in five, and malignant in 51. The excised
specimen was < 4 cm in 76.6% (82/107) of the benign cases (mean; 2.7 cm). The
pathologist could identify the mass around the tattoo and was able to make a spe-
cific diagnosis in 81.3% (87/107) of benign lesions. The only complication
encountered was residual charcoal marking along the incision scar (3.6%). All fol-
low-up US documented the removal of the lesions. 
Conclusion: An US-tattoo for nonpalpable breast lesions is a very simple and
accurate method that can help surgeons design and schedule an open biopsy.
he rate of imaging-detected nonpalpable breast lesions has increased with
the advent of routine screening for breast cancer (1). A nonsurgical core
needle biopsy helps decrease the frequency of unnecessary surgery by
obtaining a histological diagnosis of imaging-detected lesions. However, these lesions
tend to be an indication for surgery when high-risk lesions such as a papilloma or
radial scar are observed by a core needle biopsy, when the patients or surgeons hope
for complete removal of the lesions, or when additional lesions are detected in the
other quadrant in a breast cancer patient scheduled to undergo conserving surgery.
A preoperative localization is very important for a minimal but accurate excision of
a nonpalpable lesion. Several techniques such as needle localization or dye injection
such as toludine blue or methylene blue have been used to localize nonpalpable breast
lesions (2 6). Needle localization is widely used but the procedure is quite compli-
cated. The complications and failure rates has been reported to range from 1 to 10%
due to a lack of communication between the radiologist and surgeon, inadequate wire
localization to the dermal calcifications and wire shifting between localization and
surgery (3, 7 10). 
In Korea, the incidence of US-only detected nonpalpable breast lesions has been
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Tincreasing with the increasing use of screening breast US.
A simple and stable localization method is essential for the
removal of these lesions, and there are many methods
currently available. These include localization with a
needle and wire system and the use of a colored dye as a
visual marker. Localization with a needle and wire system
and dying with toluidine blue or methylene blue should be
performed on the day of the operation regardless of the
radiologist’s schedule because of the risk of needle
displacement and fast dye dispersion (2, 5). However, a
charcoal suspension is so stable that surgery can be
delayed for days or even weeks. 
Svane (6) introduced the use of a charcoal suspension for
preoperative marking of nonpalpable breast lesions using
stereotactic techniques. However, there are no reports of
the use of a charcoal suspension under US guidance. To
our knowledge, this is the first study tailored exclusively to
US guided cases of charcoal marking. This report
introduces the procedure of US-guided tattooing localiza-
tion (US-tattoo) using a charcoal suspension for nonpalpa-
ble breast lesions. 
MATERIALS AND METHODS
Full informed consent for the procedure was obtained
from all patients and institutional review board approval
was obtained. Between March 1996 and July 2001, 164
nonpalpable breast lesions detected by US in 134 preoper-
ative patients underwent a US-tattoo. The patient’s age
was 30 74 years (mean age, 47 years). 
Mammograms were available in 115 patients with 136
lesions. The mammographic findings were divided into
mass, calcifications, asymmetric density, architectural
distortion, or none (Table 1). Mammograms were not
performed in 19 patients. The US findings of the 164
targeted lesions were shown as a mass, a non-mass forming
lesion, and metastatic lymph nodes (Table 1). The US-
tattoo was carried out by one of two board-certified radiol-
ogists. The mammographic and sonographic Breast
Imaging Reporting and Data System (BI-RADS) catego-
rization were also performed (Table 2). 
The tattooed lesions had a preoperative pathological
result by a core needle biopsy (n = 61) or fine needle
aspiration (n = 5) in 66 lesions from 63 patients. The
pathology results of the core needle biopsy revealed 25
malignant, 26 borderline, and 10 benign lesions, and the
cytology results showed four atypical cells and one
papillary neoplasm (Table 3). A surgical excision was
performed in 109 lesions. Eleven of these 109 lesions were
pathologically verified as benign lesions by a core needle
biopsy or fine needle aspiration. These eleven benign
lesions and the remaining 98 lesions were surgically
removed because they coincided with breast cancer or the
imaging findings were typical for surgical indication (e.g.
Ko et al.
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Table 1. The Imaging Findings of the 164 Tattooed Lesions in 136 Patients
Mammographic Finding Number of Lesions (%)* Ultrasonographic Finding Number of Lesions (%)*
Mass 18 (11.0) Mass  154 (93.9)
Focal asymmetry 34 (20.7) Non-mass  8 (4.9)
Architectural distortion 6 (3.7) Lymph node 2 (1.2)
Calcifications 9 (5.5)
Negative 69 (42.1)
Not done 28 (17.1)
Total 164 (100.0) Total 164 (100.0)
Note. *The numbers in the parentheses are percentages.
Masses include complex or complicated cysts. 
Non-mass lesions are hypoechoic lesions without a definite margin.
Table 2. BI-RADS Categories of the 164 Tattooed Lesions in 136 Patients
BI-RADS Category* Number of Lesions (%)   in Mammogram Number of Lesions (%)   in Ultrasonogram
3 95 (57.9) 95 (57.9)
4 55 (33.6) 53 (32.3)
5 14 (8.5)  16 (9.8)
Total 164 (100.0) 164 (100.0)
Note. *BI-RADS = Breast Imaging Reporting and Data System
The numbers in the parentheses are percentages.suspicious malignancy or intraductal papilloma) or the
patient requested the procedure. 
A sterilized 3% w/w aqueous suspension of activated
charcoal granules (Duksan Pure Chemical, Ansan, Korea)
was prepared in the division of the pharmaceutical services
at our institution. 0.3 gm of activated charcoal was added
to 10 ml of normal saline, and the suspension was filtered
through a blue filter with a 0.2  m pore size. The prepara-
tion was distributed in 10 ml bottles, and sterilized with
120 steam over a period of 20 minutes. 
After identifying the lesions by US, < 1 cc 1% lidocaine
of was injected into the skin directly over the lesion
selectively in sensitive patients. During the procedure, the
assistant technician kept agitating the charcoal bottle to
prevent settling. Approximately 2 cc of the charcoal
suspension was aspirated using a 10-ml syringe and a
needle was substituted with an 18-gauge needle in order to
prevent blockage by precipitation. A syringe with an 18-
gauge needle was inserted into the lesion vertically
(antiparallel to US probe) with freehand US-guidance. The
charcoal suspension was injected slowly as the needle was
withdrawn to the point of skin entry. Caution was taken to
prevent too much charcoal being injected just beneath the
skin in order to prevent an unnecessary residual skin
tattoo. The injected volume of the charcoal suspension was
< 1 ml. 
The procedure time was measured from the time of skin
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Fig. 1. A 67-year-old woman with a dense pattern on the screening mammogram.
A. Ultrasonogram shows a 0.5 cm-sized, irregular taller shaped and hypoechoic
solid nodule.
B. Photomicrograph of the specimen after the US-tattoo shows a small infiltrative
ductal cancer. Adjacent to the mass, charcoal markings are observed as black
particles (black arrows). (Hematoxylin & Eosin staining; original magnification,  40)
A
B
Table 3. The Histology Results of the Preoperative Core
Biopsy or Aspiration in 66 Lesions
Core Biopsy Number of Lesions (%)*
Malignant
Invasive ductal carcinoma 19 (28.8)
Invasive lobular carcinoma  1 (1.5)
Ductal carcinoma in situ 4 (6.1)
Tubular cancer 1 (1.5)
Total 25 (37.9)
Benign
Fibroadenoma 4  (6.1)
Fibrocystic change  3 (4.5)
Others 3 (4.5)
Total 10 (15.1)
Borderline or high risk
Atypical ductal hyperplasia 10 (15.1)
Mucocele-like lesion 1 (1.5)
Phyllodes tumor 1 (1.5)
Sclerosing Adenosis 1 (1.5)
Papillary lesions  13 (19.7)
Total 26 (39.4)
Aspiration Number of Lesions (%)*
Atypical cell 4
Papillary neoplasm 1
Total 5 (7.6)
Note. *The numbers in the parentheses are percentages.
Benign other lesions include stromal fibrosis and ductal hyperplasia.
Papillary lesions include five papillomas, seven intraductal papillomas
and one atypical papilloma.sterilization using betadine to needle retrieval after infiltra-
tion the charcoal suspension.
The US findings, the medical records associated with US-
tattoo (technical problem, specimen size, tattoo visualiza-
tion, complication) and the pathology results were
reviewed. The pathology results were divided into benign
lesions (i.e. fibroadenoma, fibrocystic change and others),
borderline lesions (i.e. atypical ductal hyperplasia,
papilloma and radial scar) and malignant lesions (i.e.
invasive carcinoma, ductal carcinoma in situ and others).
The first follow-up US was carried out within six months
after surgery, and an attempt was made to determine if
there was some abnormality within or around the tattooing
and surgical site. 
RESULTS
Of ten benign and 26 borderline lesions by the core
biopsy or cytology, five lesions were upgraded by surgery:
two benign lesions to atypical ductal hyperplasia, two
atypical ductal hyperplasias to an invasive ductal
carcinoma and one ductal carcinoma in situ and papilloma
to a ductal carcinoma in situ (Table 3).
The size of the lesions ranged from 0.4 cm to 3.2 cm,
averaging approximately 1.0 cm. Multiple (2 4) lesions
were tattooed in 24 patients. 
The pathologist could easily identify the targeted lesion
around the tattoo in all cases (Figs. 1, 2) except for one.
Although the tumor area was partly masked by the tattoo,
there was no significant interference with the pathological
diagnosis . The pathology findings were benign lesions (n =
85), borderline lesions (n = 28) and malignant lesions (n =
51) (Table 4). The lesion size was 0.5 3.2 cm (mean size
1.0 cm) and the specimen size was 0.7 4 cm (mean size
2.7 cm). 
The procedure took approximately 5 minutes (range, 2
10 minutes) per lesion, and almost all patients tolerated the
Ko et al.
298 Korean J Radiol 8(4), August 2007
Table 4. The Histology Results of Tattooed Lesion Based on
the Pathology at Surgery in 164 Cases
Histologic Types Number of Lesions (%)*
Malignant
Invasive ductal carcinoma 31 (18.9)
Metastatic lymph node 2 (1.2)
Ductal carcinoma in situ 10 (6.1)
Tubular cancer 6 (3.6)
Invasive lobular carcinoma 1 (0.6)
Papillary cancer 1 (0.6)
Total 51 (31.1)
Benign
Fibroadenoma 42  (25.6)
Fibrocystic change 23 (14.0)
Others 20 (12.2)
Total 85 (51.8)
Borderline
Papilloma 22 (13.4)
Atypical ductal hyperplasia 5 (3.1)
Radial scar 1 (0.6)
Total 28 (17.1)
Note. *The numbers in the parentheses are percentages.
Other benign lesions include stromal fibrosis, ductal hyperplasia,
adenosis, duct ectasia, mucocele-like lesions, and benign phyllodes
tumor. 
Fig. 2. A 31-year-old woman presented for screening. 
A. Ultrasonogram shows a 1.3-cm-sized, complex cystic mass. 
B. Photomicrograph of the specimen after the US-tattoo shows a cystically dilated duct, containing charcoal (white arrows) and inflam-
matory exudates. (Hematoxylin & Eosin staining; original magnification,  40)
ABUS-tattoo procedure well. 
The technical problems encountered include blockage of
the needle tip and difficulty in advancing the needle.
Blockage of needle tip by precipitated charcoal particles
was an occasional problem (8/164, 4.9%). Strong pressure
to the blocked needle relieved the blockage in all eight
cases. When resistance was felt within the hard masses, the
charcoal solution was injected only superficially into the
mass. Sometimes, it was difficult to advance the needle in
an extremely dense breast. In these cases, the needle was
reinserted through another route adjacent to the first entry
site. 
Pain and bleeding were minor complications associated
with the procedures. These complications were managed
by lidocaine infiltration and local compression. 
The mean time between the tattooing and surgery was
1.4 days (from immediately before surgery to a maximum
of 57 days). Surgery was usually performed on the same
day (n = 84) or the next day after the US-tattoo (n = 45)
but it was occasionally delayed from three to 57 days after
the US-tattoo (n = 5). The surgeon precisely identified the
tattoo in 163 out of 164 cases, even in those cases in whom
surgery had been delayed. In one case, the on-day tattoo
was tinged so scantly in the superficial portion of the lesion
that the surgeon could not be guided by the tattoo and an
unwanted wide excision was performed. The possible
cause of failure in this case might have been the forced
injection of a blocked needle tip, which reduced the
amount of the diluted tattooed solution remaining in the
lesion. The final pathological result was fibrocystic change
without a specific diagnosis. 
All patients except for two were examined with US
within six months after surgery. There were no cases with
residual or recurred masses or lesions at tattooing sites.
The sole complication was a cosmetic problem, i.e. residual
linear tattooing of the skin after surgery in two patients
(Fig. 3). 
DISCUSSION
The increasing number of nonpalpable breast lesions
being detected during US screening of the breast has
highlighted the need for the rapid and precise localization.
Among the several techniques, needle localization is
widely used. However, there is a high rate of complications
and failure (3, 7 10).
Although the optimal time for wire localization was
thought to be immediately before surgery, it is difficult in
practice. Wire localization is sometimes performed one day
before surgery. In this case, the migration or withdrawal of
the localized wire might be problematic. Sometimes, the
removal of an anchored wire can occur if the operation
was suspended due to the poor general condition of the
patient, e.g., the heart is not strong enough to endure the
procedure and general anesthesia. 
In contrast, an US-tattoo is rapid and easy to perform
with minimal patient discomfort. The stability of charcoal
marking over time is one of its strengths (6, 11, 12).
Because activated charcoal is in particulate form and
insoluble in water, it remains within the track and does not
disperse to the surrounding tissue, which is in contrast to
methylene blue. Therefore, the tracing of the charcoal
tattoo during surgery makes it easy to locate the lesion,
which means that surgery can be planned over a period of
many days. In addition, no particular equipment or instru-
ments are needed, and charcoal is biologically inert and
has been used in skin tattoos for centuries (13). A
histopathology examination of the charcoal specimens
revealed only low-grade foreign body reactions. The
patients who had received charcoal, including many who
were followed up for several years, showed no adverse
symptoms (12). Furthermore, the use of charcoal for breast
marking has been demonstrated to be safe in other studies
(6, 11, 12) that examined stereotactically guided carbon
localization in combination with fine-needle aspiration and
hookwire localization. The fixation of charcoal particles by
phagocytosis subsequently occurs. This permanently marks
the track, which means that it can be used before neoadju-
vant chemotherapy (14, 15). 
Mullen et al. (16) reported that the marking of stereotac-
tic biopsy track with a charcoal suspension was safe and
effective in place of additional preoperative needle
localization (17 20). If the targeted lesion is completely
removed with a vacuum-assisted biopsy, the accurate
placement of a clip or marker at the biopsy site will facili-
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Fig. 3. Photograph of the left breast after breast conserving
surgery demonstrates a residual charcoal stain along the scar. tate accurate placement of the localizing needle in those
lesions requiring surgical excision. In these cases, an US-
tattoo might be helpful in identifying the previous lesion
site (16). 
The material needed for an US-tattoo is readily available
and cost effective. Moreover the method of preparation is
not difficult, as described above. 
In our series, the most serious problem during the
injection was a blockage of the needle tip by charcoal
particles. The pop-up of charcoal particles could be
prevented by continuously shaking the bottle. An injection
under excessive pressure should be avoided if there is any
resistance at the time of the charcoal injection. Another
technical complication was that needle insertion was too
tight to advance in an extremely dense breast. In this case,
another route should be found. 
Many complications are possible. Among them, pain and
bleeding sometimes occurred, which were controlled by
additional local anesthesia and local compression. Residual
charcoal marking at the skin after procedure was another
complication, which was managed by the additional
removal of a skin stripe during surgery.
There are some advantages in US-tattoo compared with
stereotactic-charcoal marking. First, breast compression
using a fenestrated paddle is essential for performing
stereotactic-charcoal marking, which cause pain and
discomfort. The second problem that can arise in stereo-
tactic-charcoal marking is the loss of the charcoal tract
during the decompression of breast after stereotactic
guidance. This is not problematic for US-guided charcoal
marking because little pressure is applied during US
scanning. Furthermore, US-guidance is more comfortable
to the patients than stereotactic guidance due to the
patient’s supine position. The disadvantage is that the
application is limited to a sonographically visible lesion.
This is not possible when the lesions are observed only by
mammography. Although the calcifications were also
observed by sonography, wire localization is
recommended because charcoal tattooing cannot be
identified on a mammogram. Hence, it is impossible to
confirm the relationship between a charcoal marked area
and a total area of calcification. However, one can substi-
tute an US-tattoo for wire localization to localize the
lesion on both US and the mammogram. One possible use
is in cases of track localization after an US or stereotactic-
guided mammotome biopsy. 
This study had several limitations. First, a long-term
follow up was not performed. Second, the number of skin
tattoos could be underestimated because they were based
on the patients’ chart. Third, a surgeon unfamiliar with this
procedure could confuse the tattoo with the foci of
bleeding or a cauterization effect.
In conclusion, US-tattoo for nonpalpable breast lesions is
a very simple, safe and accurate method. After the US-
tattoo, the radiologist and surgeon can schedule surgery
according to their timetable, and safely delay the surgery
time in unavoidable situations.
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